SKSylvia Knapp

Sylvia Knapp

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Sylvia Knapp has a total of 1000 co-authors. Here are the top co-authors by number of shared publications:

  • Anastasiya Hladik

    Research Division of Infection Biology, Department of Medicine I, Medical University of Vienna, Vienna, Austria

    33 shared publications
  • Karin Lakovits

    Research Division Infection Biology, Department of Medicine I, Medical University of Vienna, Austria

    24 shared publications
  • Omar Sharif

    Institute for Vascular Biology, Centre for Physiology and Pharmacology, Medical University of Vienna, Vienna, Austria

    18 shared publications
  • Tom van der Poll

    Center for Experimental and Molecular Medicine, Academic Medical Center, University of Amsterdam , Amsterdam

    17 shared publications
  • Riem Gawish

    Research Division of Infection Biology, Department of Medicine I, Medical University of Vienna, Vienna, Austria

    14 shared publications
  • Sandrine Florquin

    Department of Pathology, Academic Medical Center, University of Amsterdam, Amsterdam, The Netherlands

    14 shared publications

Latest Publications

  • Open Access

    A CD4-lineage erythro–myeloid progenitor within the adult bone marrow defines an alternative pathway for macrophage generation

    by Shweta Tikoo, Rohit Jain, Brendon Martinez, Renhua Song, Matthias Wielscher, Carlos Márquez-Burgoa, Anastasiya Hladik, Simone Rizzetto, Lisa E. Shaw, Minoo Ghannadan, et al.

    Tissue-resident macrophages originate from distinct developmental sources, but their adult replenishment is thought to depend exclusively on circulating monocytes. Here we identify a previously unrecognized CD4-lineage erythro–myeloid progenitor (EMPROR) in the adult bone marrow that provides an alternative pathway for macrophage generation. EMPROR cells are phenotypically and transcriptionally distinct from hematopoietic stem cells, common myeloid progenitors and monocyte precursors, lacking Csf1r and Ccr2 while expressing Cd4 and Kit . Single-cell RNA sequencing, RNA velocity analysis and lineage assays reveal macrophage, neutrophil, megakaryocytic and erythroid potential. EMPROR cells generate perivascular and tumor-associated macrophages independently of CCR2-mediated monocyte recruitment and contribute to erythroid and granulocytic lineages under inflammatory and neoplastic conditions. Transcriptomic comparisons position EMPROR cells closest to embryonic erythro–myeloid progenitors, indicating the persistence of an embryonic-like program in adult bone marrow. These findings reveal an alternative pathway of adult myelopoiesis that sustains macrophage diversity beyond the classical monocyte lineage.


  • Open Access

    The maternal–fetal interface is an early hematopoietic niche enriched in distinct erythro-myeloid progenitors

    by Rohit Jain, Shweta Tikoo, Carlos Márquez-Burgoa, Stephanie A. Gerhofer, Brendon Martinez, Mariagiovanna Barresi, Dörte Symmank, Minoo Ghannadan, Barbara Öhler, Anna-Lena Höbler, et al.

    Embryonic hematopoiesis is thought to occur exclusively in the extraembryonic yolk sac before hematopoietic stem cells (HSCs) arise in the aorta–gonad–mesonephros region. Here we identify a previously unrecognized hematopoietic site at the maternal–fetal interface in mice, termed MIXER (Maternally Interfaced eXtraEmbRyonic) tissue, which develops contemporaneously with the yolk sac and exhibits robust hematopoietic activity. MIXER contains abundant hematopoietic precursors, including classical CSF1R + erythro-myeloid progenitors and a unique embryonic CD4 + CSF1R − Erythro-Myeloid PRogenitOR (eEMPROR) population. Lineage-tracing experiments demonstrate that eEMPROR cells contribute to select macrophage subpopulations during fetal development, primarily in the perivascular space. Notably, early human placental villi, before HSC emergence, also harbor CD4 + nucleated erythrocytes, indicating a conserved hematopoietic role for the maternal–fetal interface. These findings establish MIXER as an anatomically distinct niche for embryonic hematopoiesis and expand the developmental map of blood cell emergence in mammals.


  • Open Access

    Pregnancy stages differentially impact maternal alveolar macrophages' function and immunity to SARS-CoV-2 infection

    by Alina Fokina, Lisabeth Pimenov-Reifeltshammer, Anastasiya Hladik, Karin Lakovits, Asma Farhat, Florian Deckert, Mariem Radhouani, Jessica Broesamlen, Fanzhe Meng, Riem Gawish, et al.


  • Top Cited Papers

    Eosinophil innate immune memory after bacterial skin infection promotes allergic lung inflammation

    by Mariem Radhouani, Asma Farhat, Anna Hakobyan, Sophie Zahalka, Lisabeth Pimenov, Alina Fokina, Anastasiya Hladik, Karin Lakovits, Jessica Brösamlen, Vojtech Dvorak, et al.

    Microbial exposure at barrier interfaces drives development and balance of the immune system, but the consequences of local infections for systemic immunity and secondary inflammation are unclear. Here, we show that skin exposure to the bacterium Staphylococcus aureus persistently shapes the immune system of mice with specific impact on progenitor and mature bone marrow neutrophil and eosinophil populations. The infection-imposed changes in eosinophils were long-lasting and associated with functional as well as imprinted epigenetic and metabolic changes. Bacterial exposure enhanced cutaneous allergic sensitization and resulted in exacerbated allergen-induced lung inflammation. Functional bone marrow eosinophil reprogramming and pulmonary allergen responses were driven by the alarmin interleukin-33 and the complement cleavage fragment C5a. Our study highlights the systemic impact of skin inflammation and reveals mechanisms of eosinophil innate immune memory and organ cross-talk that modulate systemic responses to allergens.


  • Top Cited Papers

    An aging bone marrow exacerbates lung fibrosis by fueling profibrotic macrophage persistence

    by Asma Farhat, Mariem Radhouani, Florian Deckert, Sophie Zahalka, Lisabeth Pimenov, Alina Fokina, Anna Hakobyan, Felicitas Oberndorfer, Jessica Brösamlen, Anastasiya Hladik, et al.

    Pulmonary fibrosis is an incurable disease that manifests with advanced age. Yet, how hematopoietic aging influences immune responses and fibrosis progression remains unclear. Using heterochronic bone marrow transplant mouse models, we found that an aged bone marrow exacerbates lung fibrosis irrespective of lung tissue age. Upon lung injury, there was an increased accumulation of monocyte-derived alveolar macrophages (Mo-AMs) driven by cell-intrinsic hematopoietic aging. These Mo-AMs exhibited an enhanced profibrotic profile and stalled maturation into a homeostatic, tissue-resident phenotype. This delay was shaped by cell-extrinsic environmental signals such as reduced pulmonary interleukin-10 (IL-10), perpetuating a profibrotic macrophage state. We identified regulatory T cells (T regs ) as critical providers of IL-10 upon lung injury that promote Mo-AM maturation and attenuate fibrosis progression. Our study highlights the impact of an aging bone marrow on lung immune regulation and identifies T reg -mediated IL-10 signaling as a promising target to mitigate fibrosis and promote tissue repair.


  • Open Access

    Linking Transcriptional and Cellular Responses of Human and Murine Pneumococcal Pneumonia

    by Anna-Dorothea Gorki, Karin Lakovits, Anastasiya Hladik, Ildiko Mesteri, Riem Gawish, Rui Martins, Barbara Drobits, Jörg Menche, Sylvia Knapp, Stefanie Widder

    Community-acquired pneumonia (CAP), often caused by Streptococcus pneumoniae , poses a significant global health challenge, especially among high-risk populations. This study investigates the temporal dynamics of pulmonary gene expression during S. pneumoniae -induced pneumonia using a murine model to elucidate host-pathogen interactions and identify potential biomarkers of disease severity. Using bulk RNA sequencing, we analyzed lung tissues at early (1h, 8h) and acute infection (2d, 3d), as well as post-resolution (30d) time-points. At 2 days post-infection, differentially expressed genes (DEGs) revealed heightened innate immune responses, including chemokine and interferon signaling pathways. By 30 days post-infection, gene expression profiles and histological changes normalized, reflecting resolution of inflammation. Stratifying mice into recovered, sick, and moribund phenotypes during the acute infection phase highlighted significant transcriptional distinctions, including upregulated pro-inflammatory genes and Schlafen family members. Arginase 1 emerged as a predictive marker of disease severity, with elevated expression detectable as early as 8 hours post-infection. Comparative analyses revealed significant overlap between transcriptional responses in our model and those from a Gram-negative Acinetobacter baumannii pneumonia model, implicating conserved pathways, such as IL-17 and Toll-like receptor signaling. Additionally, murine DEGs correlated with human plasma proteins associated with severe CAP, including CCL8 and CD14, suggesting translational relevance. This study underscores phase-specific transcriptional reprogramming during pneumococcal pneumonia and identifies potential biomarkers and therapeutic targets for improving outcomes in severe CAP cases.

  • Open Access

    Nuclear receptor corepressor 1 controls regulatory T cell subset differentiation and effector function

    by Valentina Stolz, Rafael de Freitas e Silva, Ramona Rica, Ci Zhu, Teresa Preglej, Patricia Hamminger, Daniela Hainberger, Marlis Alteneder, Lena Müller, Monika Waldherr, et al.

    FOXP3+ regulatory T cells (Treg cells) are key for immune homeostasis. Here, we reveal that nuclear receptor corepressor 1 (NCOR1) controls naïve and effector Treg cell states. Upon NCOR1 deletion in T cells, effector Treg cell frequencies were elevated in mice and in in vitro-generated human Treg cells. NCOR1-deficient Treg cells failed to protect mice from severe weight loss and intestinal inflammation associated with CD4+ T cell transfer colitis, indicating impaired suppressive function. NCOR1 controls the transcriptional integrity of Treg cells, since effector gene signatures were already upregulated in naïve NCOR1-deficient Treg cells while effector NCOR1-deficient Treg cells failed to repress genes associated with naïve Treg cells. Moreover, genes related to cholesterol homeostasis including targets of liver X receptor (LXR) were dysregulated in NCOR1-deficient Treg cells. However, genetic ablation of LXRβ in T cells did not revert the effects of NCOR1 deficiency, indicating that NCOR1 controls naïve and effector Treg cell subset composition independent from its ability to repress LXRβ-induced gene expression. Thus, our study reveals that NCOR1 maintains naïve and effector Treg cell states via regulating their transcriptional integrity. We also reveal a critical role for this epigenetic regulator in supporting the suppressive functions of Treg cells in vivo.


  • Mast cell–derived BH4 and serotonin are critical mediators of postoperative pain

    by Philipp Starkl, Gustav Jonsson, Tyler Artner, Bruna Lenfers Turnes, Laura-Marie Gail, Tiago Oliveira, Aakanksha Jain, Nadine Serhan, Karel Stejskal, Karin Lakovits, et al.

    Postoperative pain affects most patients after major surgery and can transition to chronic pain. The considerable side effects and limited efficacy of current treatments underline the need for new therapeutic options. We observed increased amounts of the metabolites BH4 and serotonin after skin injury. Mast cells were primary postoperative sources of Gch1 , the rate-limiting enzyme in BH4 synthesis, itself an obligate cofactor in serotonin production by tryptophan hydroxylase (Tph1). Mice deficient in mast cells or in mast cell–specific Gch1 or Tph1 showed drastically decreased postoperative pain. We found that injury induced the nociceptive neuropeptide substance P, mast cell degranulation, and granule nerve colocalization. Substance P triggered serotonin release in mouse and human mast cells, and substance P receptor blockade substantially ameliorated pain hypersensitivity. Our findings highlight the importance of mast cells at the neuroimmune interface and substance P–driven mast cell BH4 and serotonin production as a therapeutic target for postoperative pain treatment.


  • Open Access

    JAK-STAT signaling maintains homeostasis in T cells and macrophages

    by Nikolaus Fortelny, Matthias Farlik, Victoria Fife, Anna-Dorothea Gorki, Caroline Lassnig, Barbara Maurer, Katrin Meissl, Marlies Dolezal, Laura Boccuni, Aarathy Ravi Sundar Jose Geetha, et al.

    Immune cells need to sustain a state of constant alertness over a lifetime. Yet, little is known about the regulatory processes that control the fluent and fragile balance that is called homeostasis. Here we demonstrate that JAK-STAT signaling, beyond its role in immune responses, is a major regulator of immune cell homeostasis. We investigated JAK-STAT-mediated transcription and chromatin accessibility across 12 mouse models, including knockouts of all STAT transcription factors and of the TYK2 kinase. Baseline JAK-STAT signaling was detected in CD8+ T cells and macrophages of unperturbed mice—but abrogated in the knockouts and in unstimulated immune cells deprived of their normal tissue context. We observed diverse gene-regulatory programs, including effects of STAT2 and IRF9 that were independent of STAT1. In summary, our large-scale dataset and integrative analysis of JAK-STAT mutant and wild-type mice uncovered a crucial role of JAK-STAT signaling in unstimulated immune cells, where it contributes to a poised epigenetic and transcriptional state and helps prepare these cells for rapid response to immune stimuli.


  • Top Cited Papers
    Open Access

    TREM2 protects from atherosclerosis by limiting necrotic core formation

    by Marie Piollet, Florentina Porsch, Giuseppe Rizzo, Frederieke Kapser, Dirk J. J. Schulz, Máté G. Kiss, Kai Schlepckow, Estrella Morenas-Rodriguez, Mustafa Orkun Sen, Julius Gropper, et al.

    Atherosclerosis is a chronic disease of the vascular wall driven by lipid accumulation and inflammation in the intimal layer of arteries, and its main complications—myocardial infarction and stroke—are the leading cause of mortality worldwide1,2. Recent studies have identified triggering receptor expressed on myeloid cells 2 (TREM2), a lipid-sensing receptor regulating myeloid cell functions3, to be highly expressed in macrophage foam cells in experimental and human atherosclerosis4. However, the role of TREM2 in atherosclerosis is not fully known. Here we show that hematopoietic or global TREM2 deficiency increased, whereas TREM2 agonism decreased, necrotic core formation in early atherosclerosis. We demonstrate that TREM2 is essential for the efferocytosis capacities of macrophages and to the survival of lipid-laden macrophages, indicating a crucial role of TREM2 in maintaining the balance between foam cell death and clearance of dead cells in atherosclerotic lesions, thereby controlling plaque necrosis.